Learn More
Medchemexpress LLC (E)-4-carboxystyryl-4-chlorobenzylsulfone | 334969-03-8 | MFCD07366276 | 99.9% | 336.8 g/mol | C16H13ClO4S | 100 MG

Supplier: Medchemexpress LLC HY101625100MG
Recilisib is a small-molecule radioprotectant that mitigates radiation-induced damage by up-regulating the PI3K/AKT cell-survival signaling cascade. Supplied as a white to off-white solid for laboratory research, the compound has been characterized in preclinical studies and is distributed for investigational use with high reported purity.
- Radioprotective activity through PI3K/AKT pathway activation.
- High purity suitable for research assays (≈99.9%).
- Solid form, soluble in dimethyl sulfoxide for experimental use.
- Available in laboratory quantities for preclinical studies (e.g., 100 mg).
- Intended for research use only; not for human use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.